LabStyle Innovations Corp. (DRIO: OTCBB)End to End Smart Solutions for Diabetics in a Mobile Age
Corporate Presentation - September 27, 2013 Aegis Healthcare Conference Las VegasDr. Oren Fuerst, Executive Chairman & Erez Raphael, President/CEO
Dario
נגטיב� לוגו
Saturday, September 28, 13
Disclaimer Regarding Forward-Looking Statements This presentation of LabStyle Innovations Corp. (the “Company”) and statements of the Company’s management or agents related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions all denote forward-looking statements within the meaning of the Act. Factors that could cause or contribute to such differences include the Company’s compliance with regulatory requirements, the Company’s status as a new public company, the impact of current and any future competition, as well as other factors and risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. In addition, readers are cautioned that any estimates, forecasts or projections contained in this presentation or as may be discussed by Company management or its agents have been prepared by Company management in good faith on a basis believed to be reasonable. However, such estimates, forecasts and projections involve significant elements of subjective judgment and analysis and no representation can be made as to their attainability. No representation or warranty (express or implied) is made or is to be relied upon as a promise or representation as to the future performance of the Company. Readers are cautioned that such estimates, forecasts or projections have not been audited and have not been prepared in conformance with generally accepted accounting principles.
נגטיב� לוגו
Saturday, September 28, 13
Delaware Company Founded 2011, based on IP from 2010
Share Price $2.79. Market Cap $55MShares Outstanding 19.284M (Float ~ 11.5M shares)Public Since March 2013 (Through S1)Raised $16M, including $10M in May 2013
Developer of Dario, an all-in-one mobile and cloud based diabetes management system with glucose measurement device, data capture and analytics, sharing and social features enabling proactive care
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
LabStyle Innovations (DRIO:OTCBB) Corporate Snapshot
Saturday, September 28, 13
נגטיב� לוגו
Saturday, September 28, 13
2013 2022
$12b
$27b(Up 170%)400m
diabetics
20-30%insulin dependent
80-120mPrimary initial target users
Global glucose self-monitoring market (primarily test strips)
Large and Growing Global Marketנגטיב� לוגו
Saturday, September 28, 13
2011 2018
$37b
$72b
2011 2030
10% CAGR
370m
550m
Source: Transparency Market Research, "Global Diabetes Devices Market and Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share and Forecast, 2011 - 2018,"
Global Diabetes (therapeutics devices and drugs) market
Number of Diabetics Worldwide
Diabetes: A Large and Growing Market נגטיב� לוגו
Saturday, September 28, 13
Creating the ‘Artificial Diabetes Brain’, as a springboard of services and products leading to healthier and better life of diabetics worldwide.
DarioValue Proposition
נגטיב� לוגו
Saturday, September 28, 13
Creating the ‘Artificial Diabetes Brain’, as a springboard of services and products leading to healthier and better life of diabetics worldwide.
DarioValue Proposition
נגטיב� לוגו
Strips
Saturday, September 28, 13
Insulin
Creating the ‘Artificial Diabetes Brain’, as a springboard of services and products leading to healthier and better life of diabetics worldwide.
DarioValue Proposition
נגטיב� לוגו
Strips
Saturday, September 28, 13
Diabetes Complications
Insulin
Creating the ‘Artificial Diabetes Brain’, as a springboard of services and products leading to healthier and better life of diabetics worldwide.
DarioValue Proposition
נגטיב� לוגו
Strips
Saturday, September 28, 13
Diabetes Complications
Insulin
Creating the ‘Artificial Diabetes Brain’, as a springboard of services and products leading to healthier and better life of diabetics worldwide.
DarioValue Proposition
נגטיב� לוגו
Strips
Saturday, September 28, 13
Dario: “Artificial Diabetes Brain”, All-in-one mobile and cloud based diabetes management system with glucose measurement device, data capture and analytics, sharing and social features
-Concluded usability and accuracy studies -Obtained CE Mark for Europe. UK, Belgium, Italy distribution agreements- Software launch on European Appstore Q4- 510(k) path for the USA
-Reimbursable, recurring, test strips revenue based model-Expanding into a hub of solutions for Diabetics (e.g. revenue from integration with smart insulin pens; clinical studies; product market testing)
-More than 400M diabetics worldwide (close to 100M are insulin dependent). -$12bn test strips market and growing ($37bn overall diabetes market) -Very little real innovation
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
LabStyle InnovationsInvestment Theme
Saturday, September 28, 13
Enter Dariowww.mydario.com
Saturday, September 28, 13
Enter Dariowww.mydario.com
Saturday, September 28, 13
נגטיב� לוגו
Saturday, September 28, 13
Social Network - Crowd Source
Multi Mobile Platform - Cloud Service
Monitoring Dario Software
Easy to use, Stylish, All in
One Monitoring
Device
Actionable Personalized
Insights
Improve Diabetic Health - Monitoring to Therapy
Dario End to End Lifecycleנגטיב� לוגו
Therapy
Insulin (Pens; pumps),
Diabetic Food,Exercise,Behavior
Saturday, September 28, 13
1990s 2000s
Glucose Self-Monitoring DevicesHave changed much over the past years
נגטיב� לוגו
Saturday, September 28, 13
http://chocolateonmycranium.blogspot.com/2011/05/changes.html#.T8Yc05kthbo
Device
Lancer
Strips
A bulky Kit Cumbersome to Carry
נגטיב� לוגו
Saturday, September 28, 13
Data is Lostנגטיב� לוגו
Saturday, September 28, 13
Smartphone-driven Glucose Meter
Lancing device and strip container
Patent-pending technology
DarioThe Device
Pocket Size Glucose Meter
Stylish and easy to use
נגטיב� לוגו
Saturday, September 28, 13
Community Based - Learn and Share
Data Analysis and Insights
Proactive Recommendation Based on Pattern Recognition
End To End Diabetes Lifestyle Management (Food, Exercise, Insulin Intake)
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
Comprehensive Platform - Patient, Care Giver, Professional Healthcare
נגטיב� לוגו
DarioThe Software
נגטיב� לוגו
Goals and Objectives via Gamificationנגטיב� לוגו
Saturday, September 28, 13
DarioThe App
נגטיב� לוגו
Saturday, September 28, 13
Physician Dietitian
NurseOthercare
givers
PatientREAL-TIME DATA
HISTORICAL DATA
TAILOR-MADE DATAANALYZED DATA
Dramatically improving information flow among patients and care givers
Saturday, September 28, 13
Phone + meter Meter + lancer
Current AttemptsCombine Hardware - Rather than providing an E2E Customer Experience
נגטיב� לוגו
Saturday, September 28, 13
Combining direct to consumers and distributors model
Test strips are typically fully reimbursed; Alignment with HC Insurance Agenda
Data enables a natural expansion into insulin delivery (e.g. smart insulin pen)
Initially: Recurring, high margin revenue from sales of strips
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
Platform enables revenue from clinical studies and data (e.g. pharma; food)
User base enables product partnerships (e.g. pharma; food)
נגטיב� לוגו
נגטיב� לוגו
Revenue ModelHighlights
נגטיב� לוגו
נגטיב� לוגו
Illustration: 5 Strips/day*$0.5/Strip*365days/year*100,000 clients>$90M/year
Saturday, September 28, 13
נגטיב� לוגו
Saturday, September 28, 13
נגטיב� לוגו
Saturday, September 28, 13
נגטיב� לוגו
Saturday, September 28, 13
Oren Fuerst, PhDExecutive Chairman
Erez RaphaelCEO & President
Tal GivolyCTO
Seasoned medtech entrepreneur and investorFormer faculty Yale and Columbia Business SchoolExtensive experience in medical devices and data mgt
Former Chief Scientist of Amdocs (NYSE:DOX)More than 25 years in software developmentSoftware inventor with more 25+ granted patents
Prof. Itamar Raz MDHead of SAB
Head of Diabetes Unit and Research Center, Hadassah Medical Center ; Israel National Council of Diabetes of the Israel Ministry of Health; President, Israel Diabetes Research Group.
20 years of experience in product design, development and commercialization. Formerly with Amdocs (NYSE: DOX) and Nokia-Siemens
Shosh FriedmanVP Clinical and Regulatory
Affairs
Former SVP Clinical and Regulatory Affairs at Given Imaging (NASDAQ:GIVN). More than 20 years in clinical, regulatory affairs and QA systems.
נגטיב� לוגו
Experienced Management Team
Saturday, September 28, 13
Oren Fuerst, PhDCo-Founder
Malcolm Hoenlein
Prof. Nahum Melumad PhD
Adam Stern
Seasoned entrepreneur and investorFounder of Tevel Global & Strategic Models Former faculty Columbia Business School. Extensive experience in medical devices and data management
CEO, Executive Vice-Chairman, Conference of Major American Jewish OrganizationsDirector, Council of Foreign Relations
Professor of Accounting and Business Law, Columbia Business SchoolConsultant to J&J, Bristol-Myers, GE
Head of Private Equity Banking at Aegis Capital and CEO of SternAegis Ventures Director inVivo, Organovo, Prolor20+ years of investment experience
David Weintraub MDCo-Founder
Co-founder, Medical Director Ramat-Aviv MCSerial entrepreneur and inventorFounder of Versamed (acquired by GE)
Itamar Raz MDHead of Diabetes Unit, Hadassah Medical CenterHead, Israel National Council of DiabetesPresident, Israel Diabetes Research Group
נגטיב� לוגו
Board of directors
Saturday, September 28, 13
Dario: “Artificial Diabetes Brain”, All-in-one mobile and cloud based diabetes management system with glucose measurement device, data capture and analytics, sharing and social features
-Concluded usability and accuracy studies -Obtained CE Mark for Europe. UK, Belgium, Italy distribution agreements- Software launch on European Appstore Q4- 510(k) path for the USA
-Reimbursable, recurring, test strips revenue based model-Expanding into a hub of solutions for Diabetics (e.g. revenue from integration with smart insulin pens; clinical studies; product market testing)
-More than 400M diabetics worldwide (close to 100M are insulin dependent). -$12bn test strips market and growing ($37bn overall diabetes market) -Very little real innovation
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
LabStyle InnovationsInvestment Theme
Saturday, September 28, 13
Dario
Thank You!
נגטיב� לוגו
Saturday, September 28, 13
Saturday, September 28, 13
Physician Dietitian
NurseOthercare
givers
Patient
Big Data and Proactive Care at its best
REAL-TIME DATAHISTORICAL DATA
TAILOR-MADE DATAANALYZED DATA
•Pattern Recognition to yield personalization of Insulin Regimen
•New regimen tested in real time
•Real-Time clinical and marketing studies potential (Recruitment; Data capture; Analysis)
•Prediction of Diabetes complications and the need for immediate actions
Saturday, September 28, 13